Dr. Mondal completed Ph. D. from Tata Institute of Fundamental Research (TIFR), Mumbai, India and then continued his postdoctoral research at the Oxford University, England and Harvard University Medical School, USA, in the areas of Molecular Pharmacology and Biomarkers. After working on toxicity...